The Wolf of Wall Street film to launch NFT offering, powered by Aventus

To celebrate the film’s 10-year anniversary, Aventus has partnered with The Wolf of Wall Street’s rights holders to produce historical collection of NFTs

LONDON, April 20, 2023 (GLOBE NEWSWIRE) — Aventus, a Web3 solutions provider for enterprises, has partnered with the film rights holders for The Wolf of Wall Street and world-leading film producers and editors to create The Wolf of Wall Street Experience: a series of NFT drops which will also act as a key to unlocking wider parts of the experience.

With a worldwide box office of almost $400M, five Oscar nominations including Best Picture, and a Guinness World Records entry for most swearing in a film, The Wolf of Wall Street’s impact on popular culture remains steadfast almost a decade after its release, with memes of the film continuing to generate millions of uses.

The Wolf of Wall Street Experience will give fans of the film and Web3 enthusiasts access to exclusive content, rewards, and experiences via a series of limited NFT drops. The NFTs will contain exclusive assets from the film, including new angles of iconic scenes, as well as authentic outfits worn by the cast, props and other memorabilia. In addition, real-life and virtual experiences will take place, including a Hollywood-style celebration of the anniversary this December.

The launch is scheduled for the second quarter of 2023, with additional benefits for early participants of the community. More information can be found on the official website: www.wolfofwallstreet.io.

The NFTs will be created by the carbon neutral Aventus Network, which is a layer 1 (parachain) on Polkadot – meaning the project will leverage the full benefits of the Polkadot ecosystem, including enhanced scalability, speed, interoperability and security. It also means NFT holders will be able to leverage the full benefits of interoperability across more than 50 blockchains, including Ethereum.

Alan Vey, Founder & CEO at Aventus, commented: “The Wolf of Wall Street is one of the most iconic films across not only popular culture more broadly, but specifically within the blockchain community. We’re thrilled to be able to bring this film to Web3 and to be a part of a historic moment for the industry as blockbuster becomes the latest sector to realise the benefits of NFTs in community building and engagement.”

Gavin Wood, Founder of Polkadot & Ethereum, added: “Polkadot’s parachain ecosystem aims to help blockchains achieve their objectives by providing enhanced scalability, security and interoperability, and it’s wonderful to watch Aventus leverage this support to enable this truly groundbreaking project.”

About Aventus
Aventus onboards enterprises to Web3, enabling them to generate new revenue streams, improve operational efficiencies, and future-proof their business. With a combined experience of over seven decades in Web3 and enterprise leadership, Aventus works with each enterprise to scope out potential use cases, and customize a SaaS-style product, as well as maintain and manage the solution – so enterprises can focus on what they do best.

www.aventus.io/

Media inquiries:
Ellie Hyman
ellie.hyman@aventus.io

GlobeNewswire Distribution ID 1000805134

Denmark takes first place in second annual World Citizenship Report, global ‘powerhouses’ lose their lustre among the mass affluent

London, United Kingdom, April 20, 2023 (GLOBE NEWSWIRE) — Denmark, Switzerland and Finland took the top three spots in the 2023 World Citizenship Report, which launched today. The World Citizenship Report ranks 188 countries across five key motivators defining citizenship for the global citizen.

Published by CS Global Partners, the world’s leading government and investment migration advisory firm, the World Citizenship Report showcases the World Citizenship Index (WCI), an innovative tool that takes a holistic approach to rank the world’s citizenships across multiple dimensions including the motivators of Safety and Security, Quality of Life, Economic Opportunity, Global Mobility and Financial Freedom.

The World Citizenship Index is the product of a research-driven approach that goes beyond ordinary concepts of passport strength by placing greater emphasis on the diverse attitudes regarding key facets of citizenship. Unlike other rating tools, the World Citizenship Index ranking is designed to reflect a citizenship’s value through the lens of high-net-worth-individuals (HNWIs) and the newest generation of global citizens: the mass affluent population.

“This year, we looked beyond HNWIs and extended our survey to the new mass affluent, a globally mobile generation who is providing fresh impetus for a renewed drive towards global citizenship. As the world around continues to change at an exponential rate, bringing with it new crises and opportunities – individuals across the globe are increasingly calling their own citizenships into question in terms of the safety, freedoms, and the prosperity they provide,” said Micha Emmett, CEO of CS Global Partners.

“This Report stands apart from other reports in the industry because it examines which countries offer the most benefits for global citizens, particularly in a post-COVID world where those that have the means are consistently searching for greater opportunities.”

This year, Denmark kicked Switzerland out of the top spot and scored the highest points. Switzerland ranked in second place and Finland retained the third spot for a second year in a row.

Notably, global superpowers such as the United States and China did not rank in the top ten, symbolising a significant shift in what these economic giants can tangibly offer the global elite. HNWIs and mass affluent citizens are searching for a better quality of life, security and financial freedoms, all aspects which have been on shaky ground since the pandemic.

The surveyed cohort chose ‘Quality of Life’ as the most important feature of citizenship, which ranked first across the World Citizenship Index’s five pillars, eclipsing both Physical Safety and Financial Freedom.

The Report found that a competitive economy, public services, and environmental sustainability are the three areas mass affluent individuals feel most let down by their governments.​

We are unfortunately living through a period where the standard of living is falling at the fastest rate in over a generation. At the end of 2022, the UK Office for Budget Responsibility reported that UK households are set to suffer a 7.1 per cent fall in living standards over the next two years, the largest decline in six decades. Furthermore, according to the latest United Nations Development Programme (UNDP) report published in the same period, living conditions in 90 per cent of the world’s countries deteriorated in 2021 – something that hasn’t been seen since the height of the previous global recession caused by the financial crisis in 2007. Moreover, the UNDP report marked the first consecutive year of decline in the 32-year history of the Human Development Index (HDI) – these trends are reflected in the current World Citizenship Index scores. For example, the United States dropped to 29th position for the Quality-of-Life motivator from 20th position previously, which shows how living standards are coming under pressure even in the world’s economic powerhouses.

“The World Citizenship Report aims to capture what truly concerns and affects a global citizen,” added Emmet. “When there are options to gain a second or third citizenship, the first question in a HNWIs mind is ‘where is the next place to be associated with?’”

“High-net-worth individuals and the mass affluent must consider a myriad of factors when deciding something as monumental as where to obtain second citizenship and build a second home. While passport strength is, of course, an important component, it is also one that is subject to the greatest change as evidenced by pandemic related travel restrictions,” she added.

As many parts of the globe recover from COVID-19 and find means to bolster their economies, a new chain of threats has emerged. The conflict in the Ukraine has not only made many nations in the northern hemisphere realise just how fragile the concept of safety and freedom is but has severely impacted energy and food security across the world.

With so much change happening so rapidly around us, it can be challenging to keep up with how all these disparate factors coming to bear on the prevailing attitudes toward global citizenship. And this is where the value of the World Citizenship Report comes into the picture. The Report continues to build on its reputation as an ambitious product reflecting the evolving nature of these attitudes toward citizenship, and one that is in tune with the defining issues of our time with respect to global citizens, including health and wellbeing, environmental sustainability, and shifting investment priorities.

The World Citizenship Index’s unique methodology relies on the experience gained through CS Global Partners unparalleled work in the citizenship solutions industry, as well as comprehensive research to evaluate 188 jurisdictions across the five motivators of citizenship out of a maximum attainable score of 100 points.

The Report’s multidimensional approach ensured that the attitudes under investigation were captured as accurately and meaningfully as possible. Consequently, rather than relying exclusively on value judgments to construct and weight the World Citizenship Index, CS Global Partners also leveraged its unparalleled network of industry experts and access to global citizens to isolate the major motivations for attaining a second citizenship. These factors were then further explored and validated by surveying the global mass affluent population on the value of second citizenship.

Thembi Saleshando
CS Global Partners
+44 (0) 207 318 4343
Thembi.Saleshando@csglobalpartners.com

GlobeNewswire Distribution ID 8812232

Geneticistas Reprodutivos Reunidos em Paris Apresentam Primeiro Teste de Sequenciamento Completo do Genoma Embriões

  • Dr. Santiago Munné, pioneiro no diagnóstico genético pré-implantação, apresentou o novo teste na Conferência PGDIS
  • Além de detectar genes herdados dos pais, o novo teste de laboratório também revela novas mutações que podem levar a doenças “de novo”, como o autismo.

PARIS, April 19, 2023 (GLOBE NEWSWIRE) — O Dr. Santiago Munné, pioneiro no diagnóstico genético pré-implantação, apresentou o primeiro teste de sequenciamento completo do genoma em embriões para representantes na Preimplantation Genetic Diagnosis International Society (20ª Conferência da Sociedade Internacional de Diagnóstico Genético Pré-implantação – PGDIS), realizada esta semana em Paris.

Em seu discurso no plenário com a presença de mais de 300 especialistas, o Dr. Munné, pioneiro em genética reprodutiva internacionalmente reconhecido, apresentou dados de validação do GenomeScreen™, teste desenvolvido pela equipe de pesquisa liderada por ele na empresa de biotecnologia GenEmbryomics.

“Sabemos desde que começamos a trabalhar com o diagnóstico de embriões em 1993 que a seleção de embriões seria fundamental para a gravidez, especialmente em pacientes mais velhas. Nos últimos 30 anos, nosso trabalho tem se concentrado em aprimorar a seleção genética de embriões, embora a abordagem diagnóstica definitiva – que fornece mais informações e melhores resultados – seja, sem dúvida, esta: sequenciamento completo do genoma do embrião usando apenas algumas células obtidas de uma biópsia. Este teste abre portas que não sabíamos que existiam”, disse Munné sobre o trabalho realizado na GenEmbryomics.

Conhecer o genoma é conhecer um embrião antes da transferência
O GenomeScreen™ é um novo e revolucionário teste de sequenciamento completo do genoma para embriões de fertilização in vitro descrito como “o teste genético mais completo de fertilização in vitro” pelas autoridades do fórum PGDIS.

O teste fornece informações altamente precisas sobre a sequência do genoma do embrião e dos pais genéticos, oferecendo às famílias os principais insights pré-implantação sobre a saúde do embrião e o prognóstico reprodutivo para a tomada decisões bem-informadas. Além disso, essas informações são inestimáveis para pessoas geradas de fertilização in vitro, pois fornecem informações sobre nutrigenômica ou orientação sobre quais medicamentos são mais geneticamente adequados para o paciente.

“Quando começamos nossa pesquisa sobre o sequenciamento de embriões, nosso objetivo era criar uma ferramenta potente e abrangente para que os médicos de fertilidade pudessem acessar dados completos para uma avaliação precisa”, disse o Dr. Nick Murphy, fundador da GenEmbryomics. “Com essa ferramenta usada com 99% de confiabilidade, sabemos que, além de fornecer informações, esse diagnóstico também aumenta substancialmente o sucesso da medicina reprodutiva”, acrescentou Murphy.

O sequenciamento de embriões aumenta o índice de sucesso da fertilização in vitro

O professor Munné, líder em genética reprodutiva de mais de 20 anos, é um importante contribuinte para seleção de embriões e o tratamento de fertilização in vitro. Com este teste, ele e sua equipe de pesquisadores solidificam o papel dos testes genéticos na medicina reprodutiva, aumentando o sucesso do tratamento.

“Os resultados apresentados na conferência são os dados de validação de um teste que irá alterar a forma como a seleção de embriões é realizada”, disse Munné. “A análise genética pré-implantação com sequenciamento completo de genoma é um passo gigantesco: entre outras coisas, informará qual embrião será implantado com sucesso, porque saberemos de antemão qual deles é verdadeiramente saudável – sem doenças herdadas dos pais ou doenças de novo, como o autismo”, conclui ele.

Sobre a GenEmbryomics
Fundada pelo Dr. Nick Murphy em 2019, a GenEmbryomics é uma empresa de biotecnologia de ponta especializada na análise genômica de embriões para determinar os candidatos mais viáveis para a implantação de fertilização in vitro. Seu trabalho proporcionará índices de maior sucesso nos ciclos de fertilização in vitro, graças aos seus algoritmos proprietários que oferecem uma seleção de embriões mais precisa e eficiente, com base em todo o genoma de cada embrião.

Para mais informação
Dulce Iborra Candela
+34 647942875
dulce@laembajadora.es

GlobeNewswire Distribution ID 8811736

Les généticiens de la reproduction réunis à Paris présentent le tout premier test de séquençage du génome entier dans des embryons

  • Le Dr Santiago Munné, un pionnier du diagnostic génétique préimplantatoire, a présenté le nouveau test lors de la Conférence PGDIS
  • Non seulement ce nouveau test de laboratoire détectera les gènes hérités des parents, mais il révèlera également les nouvelles mutations pouvant mener à des maladies « de novo » comme l’autisme

PARIS, 20 avr. 2023 (GLOBE NEWSWIRE) — Le Dr Santiago Munné, pionnier du diagnostic génétique préimplantatoire, a présenté le premier test de séquençage du génome entier sur des embryons devant les participants à la 20e Conférence de la Société internationale de diagnostic génétique préimplantatoire (PGDIS pour Preimplantation Genetic Diagnosis International Society), organisée cette semaine à Paris.

Lors de son allocution plénière à laquelle ont assisté plus de 300 experts, le Dr Munné, un précurseur de la génétique de la reproduction de renommée internationale, a présenté des données de validation pour GenomeScreen™, le test développé par l’équipe de recherche qu’il dirige dans la société de biotechnologie GenEmbryomics.

« Nous savions, depuis que nous avons commencé à travailler sur le diagnostic embryonnaire en 1993, que la sélection embryonnaire serait déterminante pour la grossesse, surtout chez les patientes plus âgées. Au cours des 30 dernières années, notre travail s’est concentré sur l’amélioration de la sélection embryonnaire génétique, même si l’approche diagnostique définitive (celle qui fournit le plus d’informations et les meilleurs résultats) sera sans aucun doute celle-ci : le séquençage du génome entier de l’embryon à l’aide de quelques cellules seulement obtenues à partir d’une biopsie. Ce test va ouvrir des portes dont nous ignorions jusqu’à l’existence », a déclaré le Dr Munné sur le travail accompli chez GenEmbryomics.

Comprendre le génome, cela signifie tout savoir sur un embryon avant le transfert
GenomeScreen™ est un nouveau test révolutionnaire sur le séquençage du génome entier pour les embryons issus de FIV, qui a été décrit par les autorités comme « le test génétique le plus complet dans la FIV » lors du forum PGDIS.

Le test apporte des renseignements extrêmement précis sur la séquence du génome de l’embryon et sur les parents génétiques, fournissant aux familles des informations préimplantatoires déterminantes sur la santé de l’embryon et le pronostic de reproduction pouvant éclairer leurs décisions. Par ailleurs, ces informations seront inestimables pour les personnes nées d’une FIV, car elles fourniront des données sur la nutrigénomique ou des conseils sur les médicaments les plus génétiquement adaptés au/à la patient(e).

« Au tout début de nos recherches sur le séquençage d’embryons, notre objectif était de créer un outil complet et puissant, qui pourrait doter les médecins de la fertilité de données exhaustives pour des dépistages de précision », s’est souvenu le Dr Nick Murphy, fondateur de GenEmbryomics. « Maintenant que nous avons cet outil et que nous l’utilisons avec une fiabilité de 99 %, nous avons conscience que ce diagnostic nous fournit des informations, mais améliore également considérablement le succès de la médecine de reproduction », a ajouté le Dr Murphy.

Le séquençage des embryons va augmenter les taux de réussite des FIV

Le professeur Munné, dont la carrière en tant que chef de file en génétique reproductive s’étend sur plus de 20 ans, a apporté d’énormes contributions à la sélection embryonnaire et au traitement de FIV. Avec ce test, lui et son équipe de chercheurs solidifient le rôle des tests génétiques dans la médecine de reproduction, augmentant le succès des traitements.

Selon le professeur Munné : « Les conclusions présentées lors de la conférence constituent les données de validation d’un test qui va changer la sélection embryonnaire telle que nous la connaissons ». « L’analyse génétique préimplantatoire avec séquençage du génome entier représente un pas de géant : entre autres choses, elle nous dira quels embryons s’implanteront avec succès, car nous saurons à l’avance lesquels sont vraiment en bonne santé, c’est-à-dire sans maladie héritée des parents ou sans maladie de novo, comme l’autisme », a-t-il conclu.

À propos de GenEmbryomics
Fondée par le Dr Nick Murphy en 2019, GenEmbryomics est une société de biotechnologie de pointe spécialisée dans l’analyse génomique des embryons afin de déterminer les candidats les plus viables pour une implantation par FIV. Son travail conduira à des taux de réussite plus élevés dans les cycles de FIV, grâce à ses algorithmes propriétaires qui permettent une sélection embryonnaire plus précise et plus efficace, basée sur le génome entier de chaque embryon.

Pour tout complément d'information
Dulce Iborra Candela
+34 647942875
dulce@laembajadora.es

GlobeNewswire Distribution ID 8811736

Lagos pays N50.7bn to retirees in 4 years

The Lagos State Government on Thursday said it had paid over N50.7 billion to 13,928 retirees, from 2019 till date.

The Commissioner for Establishments, Training and Pensions, Mrs Ajibola Ponnle, made this known during the 100th Retirement Bond Certificate Presentation Ceremony, organised by the Lagos State Pensions Commission at Ikeja.

Ponnle, who was represented by the Permanent Secretary, Office of Establishments and Training, Mr Olawale Musa, said that the payments were made to retirees in the mainstream, local government, State Universal Board, Teaching Service Commission and other state parastatals.

She also said that the state government had paid accrued pension rights of N5 billion into the Retirement Savings Accounts of 1,768 retirees, alongside their monthly contributions.

According to her, the present administration has been consistent in the payment of pension obligations to its retirees, thereby, maintaining leading role in the administration of the Contributory Pension Scheme.

Ponnle said the Bond Certificates presentation ceremony was a testament to the state government’s faithfulness in the performance of its obligations to retirees.

She said that the government was grateful for the diligence and commitment of the retirees while in active service.

Ponnle added that it was the recognition of the need to protect their retirement benefits that informed the implementation of the Contributory Pension Scheme.

She said that the present administration was currently working on some reforms, based on global best practices, to reduce post-retirement financial difficulties.

The commissioner said that the state government was committed to building an environment that remained safe and secure for all residents.

Ponnle also said that the state government would continue to raise the bar of governance to improve the livelihood of all residents.

Source: News Agency of Nigeria

World TB Day to be observed in Tsumkwe

World Tuberculosis (TB) Day will this year be observed in Tsumkwe in the Otjozondjupa Region, the Ministry of Health and Social Services (MoHSS) has announced.

The number of reported tuberculosis cases in Namibia has steadily declined from a high of 16 156 in 2004 to 8 100 in 2020, the health ministry highlighted in a press release on Thursday.

Despite this decline, however, the country remains among the top 30 high tuberculosis burden countries in the world. According to the Global TB Report 2020, an estimated 2 700 people died from TB in Namibia in 2019.

The MoHSS in collaboration with development partners and civil society organisations will observe World TB Day under the theme ‘Yes! We Can End TB. Save Lives’ on 27 April 2023, with Health Minister Dr Kalumbi Shangula expected to deliver the keynote address.

This year’s World Tuberculosis Day aims to disseminate information about TB in order to encourage the media to spread awareness about the disease and to make people aware of their role in ending TB by 2035, according to the ministry.

Source: The Namibian Press Agency